NewAmsterdam Pharma N.V.
NAMS | NASDAQ
$19.96
-$0.10 (-0.50%)
Nov 2, 2026, 11:24 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -147.97M | -101.2M | -92.29M | -109.54M | -165.71M | -187.36M | -241.6M | -198.92M | -228.36M | -227.64M | -175.89M | -164.44M | -123.13M | -86.02M | -42.61M | -3.64M | 2.87M | 2.75M | 4.18M | 1.81M | -1.36M | -1.49M |
Depreciation & Amortization | 244K | 230K | 220K | 212K | 176K | 150K | 113K | 75K | 53.15K | 47.15K | 41.15K | 15K | 8.85K | -4.15K | -13.15K | n/a | n/a | n/a | n/a | 250 | 500 | 750 |
Stock-Based Compensation | 33.39M | 30.19M | 45.4M | 54.82M | 39.81M | 32.92M | 25.62M | 22.21M | 27.77M | 25.04M | 24.74M | 20.65M | 15.09M | 9.53M | 1.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -4.99M | -32.57M | -14.14M | -28.24M | -21.52M | -75K | -10M | -8.77M | -4.77M | -4.1M | 69.82K | 473.86K | -95.28K | 3.06M | 671.85K | 3.87M | 2.03M | 144.06K | 227.9K | 182.2K | -33.12K | 34.78K |
Other Non-Cash Items | -28.88M | -45.6M | -81.84M | -58.05M | 23.05M | 26.05M | 89.97M | 37.82M | 36.32M | 45.44M | 7.18M | 16.24M | 16.15M | 14.91M | 10.07M | -444.73K | -5.03M | -3.22M | -4.54M | -4.08M | -1.91M | -2.83M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -247K | -25.53M | -19.28M | -31.82M | -21.44M | -12.19M | -32.67M | -15.36M | -12.76M | 4.82M | 14.37M | 58.27M | 57.7M | 56.52M | 57.06M | 3.87M | 2.03M | 144.06K | 227.9K | 50.2K | -297.12K | -361.22K |
Operating Cash Flow | -143.46M | -141.92M | -147.78M | -144.39M | -124.12M | -140.43M | -158.56M | -154.16M | -176.98M | -152.3M | -129.56M | -69.27M | -34.19M | -5.06M | 26.41M | -215.05K | -129.06K | -329.6K | -138.38K | -2.22M | -3.56M | -4.68M |
Capital Expenditures | -260K | -268K | -246K | -149K | -182K | -303K | -672K | -672K | -606.35K | -402.35K | -24.35K | -130.78K | -121.43K | -116.43K | -109.43K | -5 | -13 | -13 | -8 | -3.25K | -6.5K | -9.75K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -217.05M | -349.58M | -296.73M | -225.19M | -193.34M | -9.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 182.4M | 160.56M | 122.06M | 71.56M | 37.16M | 12.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -62.18M | -62.18M | -62.18M | -62.18M | n/a | -2.59M | -2.59M | -2.59M | -2.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.25K | 6.5K | 9.75K |
Investing Cash Flow | -34.91M | -189.28M | -174.92M | -215.95M | -218.54M | -59.61M | -62.85M | -672K | -3.2M | -2.99M | -2.62M | -2.72M | -121.52K | -116.52K | -109.52K | n/a | n/a | n/a | n/a | -3.25K | -6.5K | -9.75K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 6.52M | 8.1M | 8.1M | 8.1M | 9.28M | 7.7M | 7.9M | 14.23M | 8.92M | 165.83M | 165.63M | 159.29M | 156.9M | n/a | n/a | n/a | n/a | 2.84M | 5.68M | 8.53M |
Financial Cash Flow | 41.68M | 34.07M | 29.52M | 472.45M | 466.61M | 467.85M | 659.51M | 202.9M | 203.04M | 204.71M | 8.92M | 165.83M | 165.63M | 159.29M | 156.86M | -45K | -45K | -45K | n/a | 2.84M | 5.68M | 8.53M |
Net Cash Flow | -138.36M | -289.48M | -280.42M | 116.99M | 133.16M | 267.27M | 431.29M | 54.42M | 29.75M | 55.58M | -111.53M | 384.06M | 416.47M | 440.9M | 466.88M | -260.05K | -174.06K | -374.6K | -138.38K | 610.75K | 2.1M | 3.82M |
Free Cash Flow | -143.72M | -142.19M | -148.03M | -144.54M | -124.3M | -140.73M | -159.24M | -154.83M | -177.58M | -152.71M | -129.59M | -67.43M | -32.34M | -3.2M | 28.27M | -215.05K | -129.07K | -329.61K | -138.39K | -2.23M | -3.57M | -4.69M |
Adj. Free Cash Flow | -177.11M | -172.38M | -193.43M | -199.36M | -164.11M | -173.65M | -184.86M | -177.04M | -205.35M | -177.74M | -154.32M | -88.08M | -47.43M | -12.74M | 26.35M | -215.05K | -129.07K | -329.61K | -138.39K | -2.23M | -3.57M | -4.69M |
Maintenance CapEx | -239K | -180K | -143.4K | -43.4K | -1.4K | -206.44K | -590.04K | -593.04K | -602.39K | -402.35K | -24.35K | -110.96K | -101.6K | -96.6K | -89.6K | 10 | n/a | n/a | n/a | -250 | -500 | -750 |
Growth CapEx | -21K | -88K | -102.6K | -105.6K | -180.6K | -96.57K | -81.96K | -78.96K | -3.96K | n/a | n/a | -19.82K | -19.82K | -19.82K | -19.83K | -15 | -13 | -13 | -8 | -3K | -6K | -9K |
Owner Earnings | -143.7M | -142.1M | -147.93M | -144.43M | -124.12M | -140.64M | -159.15M | -154.75M | -177.58M | -152.71M | -129.59M | -67.41M | -32.32M | -3.18M | 28.29M | -215.04K | -129.06K | -329.6K | -138.38K | -2.22M | -3.56M | -4.68M |
Add to Watchlist
Select watchlists to add or remove NAMS